These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
226 related articles for article (PubMed ID: 23184791)
1. Polyvalent mesoporous silica nanoparticle-aptamer bioconjugates target breast cancer cells. Li LL; Yin Q; Cheng J; Lu Y Adv Healthc Mater; 2012 Sep; 1(5):567-72. PubMed ID: 23184791 [TBL] [Abstract][Full Text] [Related]
2. Controlled intracellular release of doxorubicin in multidrug-resistant cancer cells by tuning the shell-pore sizes of mesoporous silica nanoparticles. Gao Y; Chen Y; Ji X; He X; Yin Q; Zhang Z; Shi J; Li Y ACS Nano; 2011 Dec; 5(12):9788-98. PubMed ID: 22070571 [TBL] [Abstract][Full Text] [Related]
3. Targeting cancer cells with controlled release nanocapsules based on a single aptamer. Hernandez FJ; Hernandez LI; Pinto A; Schäfer T; Özalp VC Chem Commun (Camb); 2013 Feb; 49(13):1285-7. PubMed ID: 23295617 [TBL] [Abstract][Full Text] [Related]
4. DNA-hybrid-gated multifunctional mesoporous silica nanocarriers for dual-targeted and microRNA-responsive controlled drug delivery. Zhang P; Cheng F; Zhou R; Cao J; Li J; Burda C; Min Q; Zhu JJ Angew Chem Int Ed Engl; 2014 Feb; 53(9):2371-5. PubMed ID: 24470397 [TBL] [Abstract][Full Text] [Related]
5. Bioresponsive controlled release using mesoporous silica nanoparticles capped with aptamer-based molecular gate. Zhu CL; Lu CH; Song XY; Yang HH; Wang XR J Am Chem Soc; 2011 Feb; 133(5):1278-81. PubMed ID: 21214180 [TBL] [Abstract][Full Text] [Related]
6. DNA-Hybrid-Gated Photothermal Mesoporous Silica Nanoparticles for NIR-Responsive and Aptamer-Targeted Drug Delivery. Zhang Y; Hou Z; Ge Y; Deng K; Liu B; Li X; Li Q; Cheng Z; Ma P; Li C; Lin J ACS Appl Mater Interfaces; 2015 Sep; 7(37):20696-706. PubMed ID: 26325285 [TBL] [Abstract][Full Text] [Related]
7. ATP-responsive controlled release system using aptamer-functionalized mesoporous silica nanoparticles. He X; Zhao Y; He D; Wang K; Xu F; Tang J Langmuir; 2012 Sep; 28(35):12909-15. PubMed ID: 22889263 [TBL] [Abstract][Full Text] [Related]
8. Aptamer-nanoparticle bioconjugates enhance intracellular delivery of vinorelbine to breast cancer cells. Zhou W; Zhou Y; Wu J; Liu Z; Zhao H; Liu J; Ding J J Drug Target; 2014 Jan; 22(1):57-66. PubMed ID: 24156476 [TBL] [Abstract][Full Text] [Related]
9. EpCAM aptamer-functionalized mesoporous silica nanoparticles for efficient colon cancer cell-targeted drug delivery. Xie X; Li F; Zhang H; Lu Y; Lian S; Lin H; Gao Y; Jia L Eur J Pharm Sci; 2016 Feb; 83():28-35. PubMed ID: 26690044 [TBL] [Abstract][Full Text] [Related]
10. Cytochrome c end-capped mesoporous silica nanoparticles as redox-responsive drug delivery vehicles for liver tumor-targeted triplex therapy in vitro and in vivo. Zhang B; Luo Z; Liu J; Ding X; Li J; Cai K J Control Release; 2014 Oct; 192():192-201. PubMed ID: 25034575 [TBL] [Abstract][Full Text] [Related]
11. Cell-specific intracellular anticancer drug delivery from mesoporous silica nanoparticles with pH sensitivity. Luo Z; Cai K; Hu Y; Zhang B; Xu D Adv Healthc Mater; 2012 May; 1(3):321-5. PubMed ID: 23184747 [TBL] [Abstract][Full Text] [Related]
12. Core/shell structured hollow mesoporous nanocapsules: a potential platform for simultaneous cell imaging and anticancer drug delivery. Chen Y; Chen H; Zeng D; Tian Y; Chen F; Feng J; Shi J ACS Nano; 2010 Oct; 4(10):6001-13. PubMed ID: 20815402 [TBL] [Abstract][Full Text] [Related]
13. A controlled-release nanocarrier with extracellular pH value driven tumor targeting and translocation for drug delivery. Zhao Z; Meng H; Wang N; Donovan MJ; Fu T; You M; Chen Z; Zhang X; Tan W Angew Chem Int Ed Engl; 2013 Jul; 52(29):7487-91. PubMed ID: 23757374 [TBL] [Abstract][Full Text] [Related]
14. Aptamer/Graphene Quantum Dots Nanocomposite Capped Fluorescent Mesoporous Silica Nanoparticles for Intracellular Drug Delivery and Real-Time Monitoring of Drug Release. Zheng FF; Zhang PH; Xi Y; Chen JJ; Li LL; Zhu JJ Anal Chem; 2015 Dec; 87(23):11739-45. PubMed ID: 26524192 [TBL] [Abstract][Full Text] [Related]
15. Functional silica nanoparticles for redox-triggered drug/ssDNA co-delivery. Ma X; Nguyen KT; Borah P; Ang CY; Zhao Y Adv Healthc Mater; 2012 Nov; 1(6):690-7. PubMed ID: 23184818 [TBL] [Abstract][Full Text] [Related]
16. Mesoporous silica nanoparticles: A multifunctional nano therapeutic system. Mai WX; Meng H Integr Biol (Camb); 2013 Jan; 5(1):19-28. PubMed ID: 23042147 [TBL] [Abstract][Full Text] [Related]
17. Mesoporous silica nanoparticle-based H2O2 responsive controlled-release system used for Alzheimer's disease treatment. Geng J; Li M; Wu L; Chen C; Qu X Adv Healthc Mater; 2012 May; 1(3):332-6. PubMed ID: 23184750 [TBL] [Abstract][Full Text] [Related]
18. Mesoporous silica nanoparticles for intracellular controlled drug delivery. Vivero-Escoto JL; Slowing II; Trewyn BG; Lin VS Small; 2010 Sep; 6(18):1952-67. PubMed ID: 20690133 [TBL] [Abstract][Full Text] [Related]
19. MUC1 aptamer-capped mesoporous silica nanoparticles for controlled drug delivery and radio-imaging applications. Pascual L; Cerqueira-Coutinho C; García-Fernández A; de Luis B; Bernardes ES; Albernaz MS; Missailidis S; Martínez-Máñez R; Santos-Oliveira R; Orzaez M; Sancenón F Nanomedicine; 2017 Nov; 13(8):2495-2505. PubMed ID: 28842375 [TBL] [Abstract][Full Text] [Related]